These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy. Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744 [TBL] [Abstract][Full Text] [Related]
6. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy]. Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595 [TBL] [Abstract][Full Text] [Related]
7. Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity. Hudgson P; Gardner-Medwin D; Pennington RJ; Walton JN J Neurol Neurosurg Psychiatry; 1967 Oct; 30(5):416-9. PubMed ID: 6062992 [No Abstract] [Full Text] [Related]
8. Steroid-induced CPK estimation--a new diagnostic test for human muscular dystrophy and its carrier state. Sen S; Das PK Arch Dis Child; 1978 Jun; 53(6):521-2. PubMed ID: 686785 [No Abstract] [Full Text] [Related]
9. Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity. Griffiths PD Clin Chim Acta; 1966 Apr; 13(4):413-20. PubMed ID: 5927331 [No Abstract] [Full Text] [Related]
10. [Serum creatine kinase activity in patients with Duchenne-type dystrophy and in their mothers following physical effort]. Hetnarska L Neurol Neurochir Pol; 1971; 5(5):653-7. PubMed ID: 5161075 [No Abstract] [Full Text] [Related]
11. The significance of the "dilution effect" in the determination of serum creatine kinase. Holt PG; Knight JO; Kakulas BA Clin Chim Acta; 1971 Jul; 33(2):455-6. PubMed ID: 5119322 [No Abstract] [Full Text] [Related]
12. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy]. Lujf A; Sluga E; Moser K Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427 [No Abstract] [Full Text] [Related]
13. Serum CPK in muscular dystrophy and myotonia dystrophica. Danowski TS; Sabeh G; Vester JW; Alley RA; Robbins TJ; Tsai CT; Pazirandeh M; Sekaran K Metabolism; 1968 Sep; 17(9):808-17. PubMed ID: 5674126 [No Abstract] [Full Text] [Related]
14. [Dilution effect of serum creatine phosphokinase and myoglobin in progressive muscular dystrophy]. Ohno T; Morikawa I; Suzuki T; Iwasa M; Mouri A No To Hattatsu; 1986 Sep; 18(5):418-20. PubMed ID: 3756026 [No Abstract] [Full Text] [Related]
15. Studies on human muscular dystrophy with particular reference to methods of carrier detection. Walton JN; Pennington RJ Ann N Y Acad Sci; 1966 Sep; 138(1):315-28. PubMed ID: 5230212 [No Abstract] [Full Text] [Related]
16. Fetal plasma carbonic anhydrase III and creatine kinase in Duchenne dystrophy. Heath R; Carter N; Jeffery S; Edwards R; Watts D; Watts R; Rodeck C Ann N Y Acad Sci; 1984; 429():620-3. PubMed ID: 6430200 [No Abstract] [Full Text] [Related]
18. Serum creatine phosphokinase in muscle disease. An evaluation of two methods of determination and comparison with serum aldolase. Bray GM; Ferrendelli JA Neurology; 1968 May; 18(5):480-4. PubMed ID: 5691174 [No Abstract] [Full Text] [Related]